Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Advances and Novel Treatment Options in Metastatic Melanoma
| Advances and Novel Treatment Options in Metastatic Melanoma |
| Autore | Facchiano Antonio |
| Pubbl/distr/stampa | Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 |
| Descrizione fisica | 1 online resource (528 p.) |
| Soggetto topico | Medicine and Nursing |
| Soggetto non controllato |
ABT-737
acetazolamide acetylcholine adjuvant therapy amoeboid motility angiogenesis apoptosis arthralgia Bcl-2 family BCL2L10 biomarkers BRAF BRAF inhibitor BRAF inhibitors BRAF-mutant melanoma cancer cancer associated fibroblast cancer stem cells carbonic anhydrase cell therapy checkpoint inhibitor cholinergic system combined therapy ctDNA CXCL10 cyclopamine cytokines cytotoxicity diagnosis DOCK4 drug resistance essential oils exosomes extracellular vesicles FAK hedgehog HIPPO HuR immunity immunotherapy interferon invasion ipilimumab lactate dehydrogenase lipid metabolism liquid biopsy liver-directed-therapies machine learning MANS peptide MARCKS mechanism of action melanoma melanoma immune infiltrate melanoma markers melanoma metastasis melanoma PDX melanomagenesis metalloproteinases metastases metastasis metastatic dormancy metastatic therapy metastatic uveal melanoma (mUM) microenvironment microRNAs MITF ML258 motility mucosal melanoma muscarinic receptors n/a nanoparticles nicotinic receptors nivolumab OXPHOS patient stratification PD-1 pembrolizumab phosphorylation plasmacytoid dendritic cells prediction principal component analysis prognosis prognostication protein tyrosine phosphatase PTPs inhibitors Rac1 radiotherapy resistance rheumatoid arthritis sex-hormones sex/gender ShcD adaptor protein siRNA slow cycling phenotype small molecules SOCE STAT3 Support Vector Machine survival target therapy targeted therapy targeted-therapy therapeutic resistance therapy TLR TPC2 tumor microenvironment tumour microenvironment uveal melanoma (UM) WNT5A |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910557612103321 |
Facchiano Antonio
|
||
| Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Emerging Functions of Septins
| Emerging Functions of Septins |
| Autore | Manoj B. Menon |
| Pubbl/distr/stampa | Frontiers Media SA, 2017 |
| Descrizione fisica | 1 online resource (126 p.) |
| Collana | Frontiers Research Topics |
| Soggetto topico | Biology, life sciences |
| Soggetto non controllato |
budding
cancer Cilia cytokinesis cytoskeleton GTPase mutation septin SOCE yeast |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910261133203321 |
|
Manoj B. Menon
|
||
| Frontiers Media SA, 2017 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Novel Biomarkers for Heart Disease
| Novel Biomarkers for Heart Disease |
| Autore | Lichtenauer Michael |
| Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020 |
| Descrizione fisica | 1 online resource (420 p.) |
| Soggetto topico | Medicine |
| Soggetto non controllato |
acute kidney injury
acute myocardial infarction AMI aneurysm aortic disease aortic regurgitation atrial fibrillation atrial myopathy biomarker biomarkers carbohydrate antigen-125 cardiac biomarkers cardiac intensive care units cardiac magnetic resonance imaging cardiometabolic disease cardiometabolic risks cardiovascular death cardiovascular diseases cardiovascular events cardiovascular risk cardiovascular surgery catestatin cell adhesion molecule ceramides ceruloplasmin chronic heart failure chronic kidney disease circulating cells circulating miRNAs CKD cohort studies coronary artery disease CVD diet quality echocardiography ejection fraction epicardial adipose tissue epicardial fat epicardial fat volume FABP3 fatty acid-binding protein 3 Framingham risk score GDF-15 GDF8 growth differentiation factor 15 (GDF-15) H-FABP healthy eating index heart failure heart failure decompensation heart-type fatty acid-binding protein heart-type fatty acid-binding protein (H-FABP) herat failure HF HFpEF HFrEF hypertension inflammatory marker KLF4 left ventricular adverse remodelling left ventricular ejection fraction left ventricular systolic function liver-type fatty-acid-binding protein long-term outcomes longitudinal strain magnetic resonance imaging magnetic resonance spectroscopy metabolic syndrome microRNA miRNA mitochondrial DNA (mtDNA) mitochondrial dysfunction muscle wasting myocardial infarction myocardial triglyceride content myostatin n/a NAFLD NAFLD fibrosis score NT-proBNP NYHA functional class obesity older women operative risk oxidative stress PBMCS Pentraxin-3 platelets PPCI pregnancy-associated plasma protein-A primary prevention reactive oxygen species (ROS) renal dysfunction repeated measurements risk prediction risk stratification saliva salivary biomarkers sarcopenia secondary prevention SOCE soluble suppression of tumorigenicity 2 (sST2) soluble urokinase-type plasminogen activator receptor (suPAR) sST2 STEMI STIM1 sudden cardiac death suPAR synthetic phenotype T1 mapping TGF-β pathway thyroid-stimulating hormone troponin vena contracta area ventricular arrhythmia ventricular tachycardia very low-density lipoprotein |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910557546203321 |
|
Lichtenauer Michael
|
||
| Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||